/ Print /

Health/Disease Strategy

Seven barriers to prescribing PCSK9 inhibitorsThe National Lipid Association releases interesting survey results on PCSK9 inhibitors prescription approval process.
Pharmaceutical pipeline: Top 4 conditions to watch
Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
Top three patient care essentialsOak Street Health co-founder tells AHIP 2017 attendees about its novel approach to patient care.
Why you need to pay attention to precision medicineDigital health pioneer Eric Topol talks about plans for a four-year precision medicine study at AHIP 2017.
Patients with complex needs require a custom approachAHIP 2017: Older adults with complex chronic conditions require payers to “look under the hood.”
Multiple myeloma treatment advances: What health execs should knowIt has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future.
Rising diabetes rates in children: Four things health execs should knowHere are four things MCOs should know about a new study focusing on young patients with diabetes.
Humana shares its population health management secretsHumana’s goal is to improve the health of the communities it serves 20% by the year 2020. Find out how it is reaching this goal.
Robust multiple myeloma treatment program holds promiseThe Medical College of Wisconsin’s multiple myeloma program is robust and growing.
Innovative strategies help fight multiple myeloma: What every exec should knowAs new scientific advancements occur at the genetic and protein levels, more strategies have been developed to identify and combat multiple myeloma.